Auxly Cannabis Cash And Equivalents vs. EBITDA
| XLY Stock | CAD 0.04 0.01 16.67% |
Cash And Equivalents | First Reported 2010-12-31 | Previous Quarter 13.2 M | Current Value 12.5 M | Quarterly Volatility 53.5 M |
For Auxly Cannabis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Auxly Cannabis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Auxly Cannabis Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Auxly Cannabis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Auxly Cannabis Group over time as well as its relative position and ranking within its peers.
Auxly |
Auxly Cannabis Group EBITDA vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. Auxly Cannabis Group is rated fourth in cash and equivalents category among its peers. It is rated third in ebitda category among its peers . At this time, Auxly Cannabis' Cash And Equivalents is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Auxly Cannabis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Auxly Cannabis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Auxly EBITDA vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Auxly Cannabis |
| = | 14.64 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Auxly Cannabis |
| = | (30.95 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Auxly EBITDA Comparison
Auxly Cannabis is currently under evaluation in ebitda category among its peers.
Auxly Cannabis Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Auxly Cannabis, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Auxly Cannabis will eventually generate negative long term returns. The profitability progress is the general direction of Auxly Cannabis' change in net profit over the period of time. It can combine multiple indicators of Auxly Cannabis, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 48.3 M | 52.4 M | |
| Operating Income | -42.2 M | -40 M | |
| Income Before Tax | -47.7 M | -45.4 M | |
| Total Other Income Expense Net | -5.6 M | -5.9 M | |
| Net Loss | -44.5 M | -42.3 M | |
| Income Tax Expense | -3.2 M | -3.1 M | |
| Interest Income | 32 K | 30.4 K | |
| Net Loss | -117.3 M | -111.4 M | |
| Net Interest Income | -25.7 M | -24.4 M | |
| Net Loss | -44.5 M | -46.7 M | |
| Change To Netincome | -581.9 K | -552.8 K | |
| Net Loss | (0.04) | (0.05) | |
| Income Quality | (0.18) | (0.18) | |
| Net Income Per E B T | 0.93 | 0.77 |
Auxly Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Auxly Cannabis. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Auxly Cannabis position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Auxly Cannabis' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Auxly Cannabis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Use Investing Themes to Complement your Auxly Cannabis position
In addition to having Auxly Cannabis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Auxly Stock
To fully project Auxly Cannabis' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Auxly Cannabis Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Auxly Cannabis' income statement, its balance sheet, and the statement of cash flows.